Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
375 GBX | 0.00% |
|
-3.85% | +12.95% |
Jul. 01 | Berenberg raises Centrica; UBS likes Rentokil | AN |
Jun. 27 | Wilmington completes disposal of European healthcare firms | AN |
Valuation
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 172.4 | 107.9 | 185.3 | 201.1 | 244 | 334.6 | - | - |
Enterprise Value (EV) 1 | 206.2 | 135.6 | 202.5 | 188 | 209 | 279.2 | 263.3 | 247.8 |
P/E ratio | 15.6 x | 21.4 x | - | - | - | 21.6 x | 24.1 x | 22.2 x |
Yield | 4.62% | - | 2.83% | 3.57% | 3.6% | 2.86% | 2.87% | 3.08% |
Capitalization / Revenue | 1.41 x | 0.95 x | 1.64 x | 1.66 x | 1.98 x | 2.56 x | 2.74 x | 2.59 x |
EV / Revenue | 1.68 x | 1.2 x | 1.79 x | 1.55 x | 1.69 x | 2.13 x | 2.16 x | 1.92 x |
EV / EBITDA | 8.49 x | 7.03 x | 9.02 x | 6.78 x | 7.43 x | 9.41 x | 8.92 x | 7.87 x |
EV / FCF | - | 9.48 x | - | 10.1 x | 7.7 x | 10 x | 8.69 x | 7.44 x |
FCF Yield | - | 10.5% | - | 9.95% | 13% | 9.96% | 11.5% | 13.4% |
Price to Book | - | - | - | 3.04 x | 3.11 x | 3.28 x | 3.01 x | 2.77 x |
Nbr of stocks (in thousands) | 87,493 | 87,359 | 87,418 | 87,427 | 87,760 | 89,218 | - | - |
Reference price 2 | 1.970 | 1.235 | 2.120 | 2.300 | 2.780 | 3.750 | 3.750 | 3.750 |
Announcement Date | 9/19/19 | 9/17/20 | 9/20/21 | 9/22/22 | 9/25/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 122.5 | 113.1 | 113 | 121 | 123.5 | 130.9 | 122.2 | 129.1 |
EBITDA 1 | 24.29 | 19.3 | 22.46 | 27.75 | 28.12 | 29.68 | 29.53 | 31.49 |
EBIT 1 | 21.45 | 14 | 16.65 | 21.62 | 24.11 | 24.34 | 23.57 | 25.26 |
Operating Margin | 17.51% | 12.38% | 14.73% | 17.86% | 19.52% | 18.59% | 19.29% | 19.56% |
Earnings before Tax (EBT) 1 | - | 6.4 | - | - | - | 22.64 | 20.61 | 22.23 |
Net income 1 | - | 4.6 | - | - | - | 15.67 | 14.08 | 15.28 |
Net margin | - | 4.07% | - | - | - | 11.97% | 11.53% | 11.83% |
EPS 2 | 0.1264 | 0.0576 | - | - | - | 0.1733 | 0.1556 | 0.1686 |
Free Cash Flow 1 | - | 14.3 | - | 18.7 | 27.13 | 27.8 | 30.3 | 33.3 |
FCF margin | - | 12.64% | - | 15.45% | 21.97% | 21.24% | 24.8% | 25.8% |
FCF Conversion (EBITDA) | - | 74.09% | - | 67.39% | 96.49% | 93.67% | 102.6% | 105.74% |
FCF Conversion (Net income) | - | 310.87% | - | - | - | 177.46% | 215.13% | 217.97% |
Dividend per Share 2 | 0.0910 | - | 0.0600 | 0.0820 | 0.1000 | 0.1073 | 0.1078 | 0.1155 |
Announcement Date | 9/19/19 | 9/17/20 | 9/20/21 | 9/22/22 | 9/25/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2021 S1 | 2021 S2 | 2022 S1 |
---|---|---|---|
Net sales 1 | - | 57.96 | 58.94 |
EBITDA | - | - | - |
EBIT 1 | - | - | 10.02 |
Operating Margin | - | - | 17.01% |
Earnings before Tax (EBT) | - | - | - |
Net income | 4.423 | - | - |
Net margin | - | - | - |
EPS | 0.0503 | - | - |
Dividend per Share 2 | - | - | 0.0240 |
Announcement Date | 2/18/21 | 9/20/21 | 2/21/22 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 33.9 | 27.7 | 17.2 | - | - | - | - | - |
Net Cash position 1 | - | - | - | 13 | 35 | 55.3 | 71.3 | 86.8 |
Leverage (Debt/EBITDA) | 1.395 x | 1.435 x | 0.7657 x | - | - | - | - | - |
Free Cash Flow 1 | - | 14.3 | - | 18.7 | 27.1 | 27.8 | 30.3 | 33.3 |
ROE (net income / shareholders' equity) | - | - | - | 24.4% | 25.6% | 19.2% | 16.6% | 16.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - | 9.13% | 7.16% | 7.62% |
Assets 1 | - | - | - | - | - | 171.7 | 196.7 | 200.5 |
Book Value Per Share 2 | - | - | - | 0.7600 | 0.8900 | 1.140 | 1.240 | 1.350 |
Cash Flow per Share 2 | - | - | - | - | - | 0.2300 | 0.2700 | 0.2800 |
Capex 1 | 3.66 | 3.8 | 3.02 | 1.73 | 1.06 | 1.48 | 1.56 | 1.64 |
Capex / Sales | 2.98% | 3.36% | 2.67% | 1.43% | 0.86% | 1.13% | 1.28% | 1.27% |
Announcement Date | 9/19/19 | 9/17/20 | 9/20/21 | 9/22/22 | 9/25/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.45% | 427M | |
+4.49% | 8.46B | |
+10.87% | 6.95B | |
+25.55% | 4.59B | |
+27.13% | 3.92B | |
+16.16% | 3.23B | |
+24.58% | 3.13B | |
-6.98% | 2.26B | |
+35.26% | 1.96B | |
-5.62% | 1.49B |
- Stock Market
- Equities
- WIL Stock
- Financials Wilmington plc